A trial of Pfizer Inc’s experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults…
Antibody levels against SARS-CoV-2, the virus that causes COVID-19, stay more durable in people who were infected by the disease and then received two doses of vaccine compared with those…
By Manas Mishra and Michael Erman The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc and BioNTech SE coronavirus vaccine for children aged 5 to 11 years,…
DAKAR: Senegal and Rwanda have signed an agreement with German company BioNTech for the construction of its first start-to-finish factories to make messenger RNA vaccines in Africa. BioNTech, which produces…
By Michael Erman NEW YORK – The U.S. Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. The vaccine from Pfizer Inc and…
By Julie Steenhuysen CHICAGO: Americans this week were handed a big decision when it comes to getting a COVID-19 vaccine booster. The U.S. Centers for Disease Control and Prevention (CDC)…
By Manas Mishra and Julie Steenhuysen The U.S. Centers for Disease Control and Prevention (CDC) on Thursday recommended the COVID-19 vaccine boosters for recipients of the Moderna Inc and Johnson…
People who received a Johnson & Johnson coronavirus vaccine may be better off with a booster shot from Moderna or Pfizer-BioNTech, according to preliminary data from a federal clinical trial…
By Johan Ahlander STOCKHOLM: Scientists behind COVID-19 vaccines could be in the running to win the Nobel Prize for Medicine even though the pandemic is far from over. Some scientists…
The WHO will take a decision on Bharat Biotech’s Covaxin for granting Emergency Use Listing (EUL) in October. While the rolling review started in July, the WHO document on the…
